Trilogy Capital’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
181,613
+416
+0.2% +$26.7K 0.44% 45
2026
Q1
$10.7M Sell
181,197
-48,249
-21% -$2.92M 0.47% 43
2025
Q4
$11.7M Buy
229,446
+7,994
+4% +$346K 0.52% 42
2025
Q3
$8.69M Buy
221,452
+6,032
+3% +$262K 0.4% 46
2025
Q2
$9.34M Buy
215,420
+6,541
+3% +$248K 0.45% 42
2025
Q1
$7.91M Buy
208,879
+13,609
+7% +$521K 0.41% 38
2024
Q4
$7.44M Buy
195,270
+2,504
+1% +$112K 0.38% 58
2024
Q3
$9.62M Sell
192,766
-336
-0.2% -$15.1K 0.49% 47
2024
Q2
$9.38M Buy
193,102
+166,759
+633% +$8.4M 0.51% 53
2024
Q1
$1.24M Buy
+26,343
New +$1.06M 0.07% 147
2018
Q4
Sell
-750
Closed -$10K 271
2018
Q3
$10K Buy
750
+2
+0.3% +$30 ﹤0.01% 327
2018
Q2
$13K Buy
748
+1
+0.1% +$17 ﹤0.01% 278
2018
Q1
$13K Buy
+747
New +$14K ﹤0.01% 245

Other funds holding FCX

Trilogy Capital's FCX Position: Q2 2026 in Review

Trilogy Capital increased its Freeport-McMoran (FCX) stake by 0.23% in Q2 2026, buying an estimated $26.7K and bringing the position to 181,613 shares worth $11.4M. The position accounts for 0.44% of the portfolio, ranked #45.

Trilogy Capital first reported a position in FCX in Q1 2018 and has held it in 13 quarters since. The position peaked at $11.7M in Q4 2025. 1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Trilogy Capital held 181,613 shares of Freeport-McMoran worth $11.4M as of Q2 2026.
  • Trilogy Capital bought 416 Freeport-McMoran shares in Q2 2026, an estimated $26.7K.
  • Freeport-McMoran made up 0.44% of Trilogy Capital's portfolio in Q2 2026, its #45 holding.
  • Trilogy Capital first reported a position in Freeport-McMoran in Q1 2018 and has held it in 13 quarters since.
  • Trilogy Capital's Freeport-McMoran position peaked at $11.7M in Q4 2025.
  • 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.